| Code | 6542A | ||||||||||
| MA number | EU/1/13/850/002 | ||||||||||
| Product Form: | cps dur 21x2 mg (blis.PVC/PCTFE/Al) | ||||||||||
| MA Status: | E - Valid centralised marketing authorisation | ||||||||||
| Type of procedure: | EU Orphan | ||||||||||
| Therapeutic Class: | 59 - IMMUNOPRAEPARATA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 48 | ||||||||||
| Container: | blister PVC/PCTFE/Al | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to restricted medical prescription. |
| Legal basis: | Article 8(3) application - new active substance |
| MA issued: | 05.08.2013 |
| SmPC + PL: |
European Medicines Agency's database
|
| Dokument: |
DHCP_Imnovid_22April16.pdf
|
| Dokument: |
Pomalidomid 2024 Prirucka pre zdravotnickych pracovnikov.pdf
|
| Dokument: |
Pomalidomid 2024 Prirucka pre pacientov.pdf
|
| Dokument: |
Pomalidomid 2024 Formular informovanosti o rizikach.pdf
|
| Dokument: |
Pomalidomid 2024 Karta pacienta.pdf
|
| Safety feature | Yes |
| Data update: | 04.05.2023 |
